Literature DB >> 23855724

HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations.

Thomas D'Aunno1, Harold A Pollack, Lan Jiang, Lisa R Metsch, Peter D Friedmann.   

Abstract

OBJECTIVE: To identify the extent to which clients in a national sample of opioid treatment programs (OTPs) received HIV testing in 2005 and 2011; to examine relationships between state laws for informed consent and pretest counseling and rates of HIV testing among OTP clients. DATA SOURCE: Data were collected from a nationally representative sample of OTPs in 2005 (n = 171) and 2011 (n = 200). STUDY
DESIGN: Random-effects logit and interval regression analyses were used to examine changes in HIV testing rates and the relationship of state laws to HIV testing among OTPs. DATA COLLECTION: Data on OTP provision of HIV testing were collected in phone surveys from OTP managers; data also were collected on state laws for HIV testing. PRINCIPAL
FINDINGS: The percentage of OTPs offering HIV testing decreased significantly from 93 percent in 2005 to 64 percent in 2011. Similarly, the percentage of clients tested decreased from an average of 41 percent in 2005 to 17 percent in 2011. OTPs located in states whose laws do not require pretest counseling and that use opt-out consent were more likely to provide HIV testing and to test higher percentages of clients.
CONCLUSIONS: The results show the need to increase HIV testing among OTP clients; the results also underscore the beneficial possibilities of dropping pretest counseling as a requirement for HIV testing and of using the opt-out approach to informed consent for testing. © Health Research and Educational Trust.

Entities:  

Keywords:  HIV testing; HIV/AIDS; health policy; opioid treatment; organizational factors; state regulation

Mesh:

Substances:

Year:  2013        PMID: 23855724      PMCID: PMC3839251          DOI: 10.1111/1475-6773.12094

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  17 in total

1.  Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Hannah K Knudsen; Brian E Bride; G Rush Smith; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-04-25

2.  State policies matter: the case of outpatient drug treatment program practices.

Authors:  Jamie F Chriqui; Yvonne Terry-McElrath; Duane C McBride; Shelby S Eidson
Journal:  J Subst Abuse Treat       Date:  2007-10-23

Review 3.  HIV prevention for injecting drug users: the first 25 years and counting.

Authors:  Don C Des Jarlais; Salaam Semaan
Journal:  Psychosom Med       Date:  2008-06-02       Impact factor: 4.312

Review 4.  Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.

Authors:  Scott S Santibanez; Richard S Garfein; Andrea Swartzendruber; David W Purcell; Lynn A Paxton; Alan E Greenberg
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

5.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Authors:  Bernard M Branson; H Hunter Handsfield; Margaret A Lampe; Robert S Janssen; Allan W Taylor; Sheryl B Lyss; Jill E Clark
Journal:  MMWR Recomm Rep       Date:  2006-09-22

6.  Private and public ownership in outpatient substance abuse treatment: do we have a two-tiered system?

Authors:  J R Wheeler; T A Nahra
Journal:  Adm Policy Ment Health       Date:  2000-03

7.  Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Lawrence S Brown; Steven Allan Kritz; R Jeffrey Goldsmith; Edmund J Bini; John Rotrosen; Sherryl Baker; Jim Robinson; Patrick McAuliffe
Journal:  J Subst Abuse Treat       Date:  2006-06

8.  An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units.

Authors:  T D'Aunno; T E Vaughn; P McElroy
Journal:  J Health Soc Behav       Date:  1999-06

Review 9.  Consistency of state statutes with the Centers for Disease Control and Prevention HIV testing recommendations for health care settings.

Authors:  Anish P Mahajan; Lara Stemple; Martin F Shapiro; Jan B King; William E Cunningham
Journal:  Ann Intern Med       Date:  2009-02-17       Impact factor: 25.391

10.  Implementing routine HIV testing: the role of state law.

Authors:  Leslie E Wolf; Alexis Donoghoe; Tim Lane
Journal:  PLoS One       Date:  2007-10-10       Impact factor: 3.240

View more
  21 in total

1.  Linkages Between Patient-centered Medical Homes and Addiction Treatment Organizations: Results From a National Survey.

Authors:  Thomas D'Aunno; Harold Pollack; Qixuan Chen; Peter D Friedmann
Journal:  Med Care       Date:  2017-04       Impact factor: 2.983

2.  Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis.

Authors:  Lydia Aletraris; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2015-04-13

3.  Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions.

Authors:  Sandra A Springer; Sarah Larney; Zahra Alam-Mehrjerdi; Frederick L Altice; David Metzger; Steven Shoptaw
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

4.  Informing Targeted Interventions to Optimize the Cascade of HIV Care Using Cluster Analyses of Health Resource Use Among People Living with HIV/AIDS.

Authors:  Emanuel Krebs; Jeong E Min; Ahmed M Bayoumi; Rolando Barrios; Julio S G Montaner; Bohdan Nosyk
Journal:  AIDS Behav       Date:  2018-01

5.  Evidence-based treatment for opioid use disorders: A national study of methadone dose levels, 2011-2017.

Authors:  Thomas D'Aunno; Sunggeun Ethan Park; Harold A Pollack
Journal:  J Subst Abuse Treat       Date:  2018-10-16

6.  Integration of Substance Abuse Treatment Organizations into Accountable Care Organizations: Results from a National Survey.

Authors:  Thomas D'Aunno; Peter D Friedmann; Qixuan Chen; Donna M Wilson
Journal:  J Health Polit Policy Law       Date:  2015-06-29       Impact factor: 2.265

7.  Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers.

Authors:  Marwan S Haddad; Alexei Zelenev; Frederick L Altice
Journal:  J Urban Health       Date:  2015-02       Impact factor: 3.671

8.  Patient-centered care's relationship with substance use disorder treatment utilization.

Authors:  Sunggeun Ethan Park; Jennifer E Mosley; Colleen M Grogan; Harold A Pollack; Keith Humphreys; Thomas D'Aunno; Peter D Friedmann
Journal:  J Subst Abuse Treat       Date:  2020-09-03

9.  Factors Associated with HIV Testing Among Participants from Substance Use Disorder Treatment Programs in the US: A Machine Learning Approach.

Authors:  Yue Pan; Hongmei Liu; Lisa R Metsch; Daniel J Feaster
Journal:  AIDS Behav       Date:  2017-02

10.  Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs.

Authors:  Jemima A Frimpong; Thomas D'Aunno; Stéphane Helleringer; Lisa R Metsch
Journal:  J Subst Abuse Treat       Date:  2015-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.